Close Menu

NEW YORK - The 39th annual JP Morgan Healthcare Conference kicked off on Monday with several drug developers, specialty pharma companies, and molecular testing firms providing updates on their precision oncology products. Below are brief reports on the presentations covered by our team. 


Merck KGaA

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.